Although CX3CR1+ CD8+ T cells are present in tumors, it remains unclear whether they directly differentiate from the CX3CR1− subset within the tumor microenvironment or are trafficked from secondary lymphoid organs via the CX3CL1/CX3CR1 chemokine axis. This evidence concerns the gene CX3CR1 and neoplasm.